Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 45

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 45
---
) expense, net (ii) (v)1.7 (0.1)(0.1)0.2 0.2 0.1 Segment EBITDA$77.1 $32.0 $0.9 $82.2 $9.3 $9.8 Six Months Ended June 30,20252024In millions, except per share dataPMPCAPTPMPCAPTNet sales (i)$300.7 $262.9 $85.5 $302.3 $332.5 $95.9 Less:Cost of sales (ii) (iii)113.2 194.6 59.3 113.5 292.1 64.8 Selling, general, and administrative expenses (ii) (iv) 32.7 37.6 12.7 28.4 40.9 11.4 Other (income) expense, net (ii) (v)(1.4)(1.0)0.1 0.2 0.8 0.4 Segment EBITDA$156.2 $31.7 $13.4 $160.2 $(1.3)$19.3 _______________(i) Relates to external customers only. Refer to Note 3 for a reconciliation to consolidated Net sales.(ii) Excludes Depreciation and amortization.(iii) Inventory charges representing lower of cost or market charges associated with the Performance Chemicals repositioning and restructuring actions were not allocated in the measurement of Performance Chemicals reportable segment profitability used by our CODM. Amounts are included in Cost of sales on the condensed consolidated statements of operations.(iv) Includes Research and technical expenses.(v) We have excluded the following items from Other (income) expense, net: gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, depreciation, and amortization.(3) The table below provides an allocation of these charges between our three reportable segments to provide investors, potential investors, securities analysts and others with the information, should they choose, to apply such (income) charges to each respective reportable segment for which the charges relate. Three Months Ended June 30,Six Months Ended June 30,In millions2025202420252024Performance Materials$— $— $— $